Sage Therapeutics' run of bad news has continued with a failed phase 2 trial of dalzanemdor as a treatment for cognitive ...

The EMA is implementing major changes to accelerate drug approvals in the EU, addressing delays that affect patients and ...

The #ESMOAmbassadors hashtag was used in 1,907 posts on X across the five-day congress. The 28 ESMO Ambassadors themselves ...

In essence, data visualisation is not just a tool for simplifying information; it is a powerful means of transforming medical ...

Donald Trump has chosen talk show host and celebrity doctor Dr Mehmet Oz to lead the Centers for Medicare and Medicaid ...

AZ and Daiichi Sankyo have said that NICE's decision on Enhertu exposes how new methods and processes the agency uses to ...

The phase 3 MK-3475A-D77 trial tested subcutaneous and intravenous Keytruda given every six weeks in combination with ...

Mendelsohn – using history as a guide – suggests there will be a layering of new laws, with, for example, a push for changes ...

Researchers from the National Institutes of Health (NIH) are applying artificial intelligence to the recruitment of ...

As Global Head of Oncology for IQVIA Biotech, Gerhard du Toit manages all aspects of oncology clinical trials, optimising ...

AI-powered chatbots will enhance HCP engagement, while comprehensive customer lifetime value prediction will enable more ...

Top-line results show that 64.7% of patients achieved clear or almost clear skin measured using the Investigator's Global ...